Skip to main content
. 2024 Jul 19;13(7):1585–1594. doi: 10.21037/tlcr-24-128

Figure 2.

Figure 2

PFS by patient background. (A) Kaplan-Meier graph of PFS in patients with durvalumab plus platinum-etoposide by age (age ≤70 years and age >70 years). (B) Kaplan-Meier graph of PFS of patients with durvalumab plus platinum-etoposide by PS (PS 0–1 and PS 2–3). CI, confidence interval; PS, performance status; PFS, progression-free survival.